Quick Takeaways
- Capital World Investors filed SCHEDULE 13G/A for NovoCure Ltd. Common Stock (NVCR).
- Disclosed ownership: 1.8%.
- Date of event: 30 Sep 2025.
Capital World Investors - 30 Sep 2025 SCHEDULE 13G/A Report for NovoCure Ltd. Common Stock (NVCR)
- Filing Manager
- Capital World Investors
- Reporting Manager
- Capital World Investors
- Security
- NovoCure Ltd. Common Stock
- Symbol
- NVCR
- Shares outstanding
- 111,111,111 shares
- Disclosed Ownership
- 2,000,000 shares
- Ownership
- 1.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Nov 2025, 19:06:14 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Capital World Investors disclosed 1.8% ownership in NovoCure Ltd. Common Stock (NVCR) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 13 Nov 2025, 19:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Capital World Investors | 1.8% | 2,000,000 | 2,000,000 | 0 | Timothy J. Moon | Vice President and Senior Counsel, Capital Research and Management Company |